InvestorsHub Logo
Followers 40
Posts 3318
Boards Moderated 0
Alias Born 08/18/2009

Re: Paullee post# 494

Friday, 11/22/2019 12:14:33 PM

Friday, November 22, 2019 12:14:33 PM

Post# of 1140
G0 glycan levels of up to 95% have been reached with this strategy. In addition to G0, only Man3and GlcNAcMan3 remain in the glycan pattern.

The glycan pattern remained good with 93-95% G0 glycans.

Summary from VTT:

? Myceliophthora thermophila C1 is an industrialized protein production host that is now developed for therapeutic protein manufacture - with several large biopharma companies entering into collaborations.

? We have identified critical proteases to deal with for therapeutic protein production enhancement and enabled a very significant reduction of the protease load in the production strains.

? Our glycoengineering program aims at high proportions of human glycoforms G0, G2, FG0 and FG2. Excellent G0 levels have been reached through alg3-alg11 deletion strategy.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DYAI News